Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma

Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma

Benjamin S Gerendash,1 Patricia A Creel2 1Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, 2Oncology, Clinical Operations, Duke University Medical Center, Durham, NC, USA Abstract: Cabozantinib is an oral tyrosine-kinase inhibitor...

Full description

Bibliographic Details
Main Authors: Gerendash BS, Creel PA
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:OncoTargets and Therapy
Subjects:
cabozantinib
adverse events management
renal cell carcinoma
targeted therapy
tyrosine kinase inhibitors
Online Access:https://www.dovepress.com/practical-management-of-adverse-events-associated-with-cabozantinib-tr-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/practical-management-of-adverse-events-associated-with-cabozantinib-tr-peer-reviewed-article-OTT

Similar Items